No abstract available
MeSH terms
-
Acute Disease
-
Animals
-
Antineoplastic Agents / adverse effects*
-
Chronic Disease
-
Humans
-
Morpholines / administration & dosage*
-
Oxaliplatin / adverse effects*
-
Peripheral Nervous System Diseases / chemically induced
-
Peripheral Nervous System Diseases / drug therapy*
-
Pyrazoles / administration & dosage*
-
Receptors, sigma / antagonists & inhibitors*
-
Sigma-1 Receptor
Substances
-
4-(2-((5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine
-
Antineoplastic Agents
-
Morpholines
-
Pyrazoles
-
Receptors, sigma
-
Oxaliplatin